https://www.avient.com/investor-center/news/avient-hold-first-quarter-2021-conference-call
Friday, April 30, 2021
Friday, April 30, 2021
Friday, April 30, 2021
https://www.avient.com/resources/safety-data-sheets?page=127
PP 401CS YELL 8645-30-04
PP 401CS RED 622-7-30-04
PP 401CS ORNG 40199-30-04
https://www.avient.com/investor-center/investor-news/archives?page=11
CLEVELAND, June 30, 2021 /PRNewswire/ -- Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, int
June 30, 2021
April 30, 2021
https://www.avient.com/investors/investor-news?page=16
30
Oct 30, 2017
PolyOne Declares Quarterly Dividend Increase of 30%, Announces Three-Year Dividend Increase Plan...
https://www.avient.com/sites/default/files/2022-04/Asia SEM Healthcare Product Selection Guide_CN.pdf
Versaflex™ OM3060
PP包覆成型 硬度 法规 灭菌 特性
28A 环氧乙烷 柔软的半透明材料,粘性好
43A 环氧乙烷 高度可着色的解决方案,粘性好,不易压缩变形
42A/ 50A 环氧乙烷 透明的耐高温级材料;ABS、PC可粘合
60A 环氧乙烷/蒸汽 弹性高,不易压缩变形
20A-90A 环氧乙烷 用途广泛,无填充
ABS,PC包覆成型 硬度 法规 灭菌 特性
40A USP VI级,ISO 10993 环氧乙烷 半透明
60A USP VI级,ISO 10993 环氧乙烷 透明
应用:
VERSAFLEX™ CL与DYNAFLEX™
热塑性弹性体
包覆成型,符合人体
工程学设计
•
•
•
•
•
•
触感柔软,有利于形成良好的表面
有多种颜色效果和纹理可供选择
提高抓握力、缓冲力和舒适度
提高性能表现,如密封性能、减震、隔氧、
耐刮擦和耐磨性能
降低装配成本,加工性能良好
可牢固包覆于各种基材上
•
•
•
•
血糖仪
医用工具包覆成型
注射笔
分析仪器
Dynaflex™ G2706
Dynaflex™ G2711
Versaflex™
CL2242 & CL2250
Versaflex™ G2705 N
Versaflex™ HC3810
Versaflex™ OM1040
USP VI级,ISO 10993,
食品接触
USP VI级,ISO 10993,
US食品接触
USP VI级,ISO 10993,
食品接触
USP VI级,ISO 10993
USP VI级,ISO 10993,
食品接触
材料描述 硬度 法规 灭菌 特性
45A USP VI级
55A USP VI级
70A USP VI级
43A 环氧乙烷
34A
USP VI级,
ISO 10993-4/5
FDA,USP VI级,
ISO 10993
57A
挤出级,耐高温
再密封,压缩变形性能提高
摩擦低
Versalloy™ HC 9210-55N
Versalloy™ HC 9210-70N
Versalloy™ HC 9220-43N
Versaflex™ HC 2110-35N
Versaflex™ HC 2110-57B FDA,USP VI级,ISO 10993
环氧乙烷 加工性能良好,表面光洁、美观
环氧乙烷
环氧乙烷
加工性能良好,表面光洁、美观
加工性能良好,表面光洁、美观
高压灭菌、环氧乙烷、
辐射灭菌
高压灭菌、环氧乙烷、
辐射灭菌
应用:
VERSALLOY™ HC与VERSAFLEX™ HC
热塑性弹性体
密封和再密封
•
•
•
•
•
柔软的橡胶质感
无抽芯,静态推塞被刺穿后再密封性良好
满足动态密封的低摩擦系数要求
可萃取物含量低
适合在聚烯烃上包覆成型
•
•
•
密封和密封隔膜
密封件和卫生垫圈
注射器推塞和塞头
Versalloy™ HC 9210-45N
材料描述 硬度 法规 灭菌 特性
65A/ 75A/ 84A
54A
67A
辐射灭菌
高压灭菌器
透明度高,不含增塑剂,无油
工作温度高,可高温灭菌
环氧乙烷、辐射灭菌
Versaflex™ HC MT555
Versaflex™ HC BT218
应用:
VERSAFLEX™ CL与DYNAFLEX™
热塑性弹性体
高透明度级,不含增塑剂
•
•
•
•
•
•
•
无色透明级,配方不含邻苯二甲酸酯增塑剂
符合医疗法规USP VI级和ISO 10993-4、5的
要求
食品接触用并符合FDA标准
可高压灭菌和辐射灭菌
可萃取物含量低
透明度高(雾度50 4.1, 100 4.5, 100 4, 70 6, 70
拉伸模量(MPa) 2200 2700 2600 2350 1820 1820
挠曲强度(MPa) 80 90 104 86 68 68
挠曲模量(MPa) 2500 2700 2500 2300 1980 1590
HDT:0.45、1.8(MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70
UL-94等级,3.0mm 5VA V-0 5VA V-0 HB V-0
UL-94等级,1.5mm V-0 V-0 5VB V-0 HB V-0
UL-94等级,0.75mm V-1 V-2 V-0 无 无 V-2
竞争材料对比
医疗保健特种工程聚合物配方
TRILLIANT™ HC热塑性塑料
Trilliant™ HC高性能热塑性弹性体系列配方是专为应对日趋严苛的医疗器械和设备而开发的。
TRILLIANT™
HC8920
TRILLIANT™
HC2020
Trilliant™ HC2020
材料描述 基料
共聚酯
Trilliant™ HC8910/8920 聚酮/ABS共混物
Trilliant™ HC2120 Tritan
Trilliant™ HC3120 PC
Trilliant™ HC5210 PP
Trilliant™ HC6010 PA6
Trilliant™ HC6610 PA66
Trilliant™ GRV-NP-110-W PA12
应用:
TRILLIANT™ HC热塑性塑料
•
•
•
•
•
作为FR PC/ABS、FR PC/PET和FR COPE的
耐化学性替代品,在各种颜色的应用中,其
阻燃等级在1.5mm和0.75mm厚度下分别可
达到UL 94黄卡V-0级和V-1级。
https://www.avient.com/resources/safety-data-sheets?page=6500
2001-BU-30 MB2 & MB3 PVC30 (Coficab)
2000-BU-30 MB2 & MB3 PVC65 (Coficab)
PP FR 8-6 LMS-1000
https://www.avient.com/sites/default/files/resources/POL%2520KeyBanc%2520IR%2520Presentation%2520w%2520non-GAAP%252009%252010%25202013.pdf
EPS: $2.50
Assumptions
• Operating margins in mid-range
of 2015 targets
• No global recession
• No investment in incremental
PP&S capacity
• Completion of 2-3 midsize
accretive acquisitions
• Housing starts at 85% of 50 year
norm by 2015
• Mid single digit revenue CAGR
• Remain comfortably below 3X Net
Debt / EBITDA
Page 11
2012
Rev: $2.9B
Adj.
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.8
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM for taxes on resin gain
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
Net debt $ 638.8
Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total
PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1
PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3
PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3
PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3
PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0
Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7
Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7
PolyOne Investor Presentation�KeyBanc 2013 Capital Markets’ �Basic Materials & Packaging Conference��September 10th, 2013�
Forward – Looking Statements
Use of Non GAAP Measures
Strategy and Execution Drive Results
Four Pillar Strategy
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Innovation Drives Earnings Growth
We are Experts in Polymer Science and Formulation
Positioned for Strong Growth
First Half 2013 Financial Highlights
Debt Maturities & Liquidity Summary – 6/30/13
Use of Cash
Why Invest In PolyOne?
https://www.avient.com/resources/safety-data-sheets?page=7139
TR BERRY PURPLE PET/30% PCR SC
TR HONEY YELLOW PET/30% PCR SC
TR COCONUT PINK PET/30% PCR SC
https://www.avient.com/resources/safety-data-sheets?page=6850
GREEN PP
TR LIME 30% PCR
TRANS RED 30% PCR
https://www.avient.com/resources/safety-data-sheets?page=6839
10140468 GN TR PP MASTERBATCH
10140516 PU TR PP MASTERBATCH
PP FR 8-6 LMS-1000